UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | O | P | R | S | T | V | W | X | Z
Number of items: 115.

A

Aganna, E; Hammond, L; Hawkins, PN; Aldea, A; McKee, SA; van Amstel, HKP; Mischung, C; ... McDermott, MF; + view all (2003) Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. ARTHRITIS RHEUM , 48 (9) 2632 - 2644. 10.1002/art.11215.

Aganna, E; Hawkins, PN; Lachmann, HJ; Bybee, A; Karenko, L; Pettersson, T; Ranki, A; ... McDermott, MF; + view all (2003) The spectrum and frequency of MEFV, TNFRSF1A, and NALP3/CIAS1/PYPAF1 mutations in patients with AA amyloidosis associated with systemic inflammation. In: AMERICAN JOURNAL OF HUMAN GENETICS. (pp. 508 - 508). UNIV CHICAGO PRESS

Alves, JD; Kumar, S; Isenberg, DA; (2003) Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. RHEUMATOLOGY , 42 (7) 893 - 899. 10.1093/rheumatology/keg248.

Andreola, A; Bellotti, V; Giorgetti, S; Mangione, P; Obici, L; Stoppini, M; Torres, J; ... Sunde, M; + view all (2003) Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-I. J Biol Chem , 278 (4) pp. 2444-2451. 10.1074/jbc.M204801200. Gold open access

B

Bates, RL; Payne, SJ; Drury, SL; Nelson, PN; Isenberg, DA; Murphy, JJ; Frampton, G; (2003) The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosus. LUPUS , 12 (8) 617 - 622. 10.1191/0961203303lu436oa.

C

Cambridge, G; Leandro, MJ; Edwards, JCW; Ehrenstein, MR; Salden, M; Bodman-Smith, M; Webster, ADB; (2003) Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. ARTHRITIS RHEUM , 48 (8) 2146 - 2154. 10.1002/art.11181.

Carulli, MT; Ong, VH; Ponticos, M; Xu, SW; Shand, L; Aden, D; Abraham, DJ; ... Denton, CP; + view all (2003) Clinical and pathological associations of monocyte chemoattractant protein-1 overexpression in scleroderma. In: ARTHRITIS AND RHEUMATISM. (pp. S670 - S670). WILEY-LISS

Cheng, KS; Tiwari, A; Boutin, A; Denton, CP; Black, CM; Morris, R; Hamilton, G; (2003) Carotid and femoral arterial wall mechanics in scleroderma. RHEUMATOLOGY , 42 (11) 1299 - 1305. 10.1093/rheumatology/keg371.

Cheng, KS; Tiwari, A; Boutin, A; Denton, CP; Black, CM; Morris, R; Seifalian, AM; (2003) Differentiation of primary and secondary Raynaud's disease by carotid arterial stiffness. EUR J VASC ENDOVASC , 25 (4) 336 - 341. 10.1053/ejvs.2002.1845.

Clapp, B; Hirschfield, G; MacAllister, R; Gallimore, R; Vallance, P; Pepys, M; Hingorani, A; (2003) C-Reactive Protein Alters Vascular Reactivity by Increasing Nitric Oxide Production. Clinical Science , 104 (s49) 4P.1-4P. 10.1042/cs104004P.

Clapp, B; Hirschfield, G; MacAllister, R; Gallimore, R; Vallance, P; Pepys, M; Hingorani, A; (2003) C-reactive protein alters vascular reactivity by increasing nitric oxide production. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. (pp. 319A - 319A). ELSEVIER SCIENCE INC

Coates, L; Erskine, PT; Mall, S; Williams, PA; Gill, RS; Wood, SP; Cooper, JB; (2003) The structure of endothiapepsin complexed with the gem-diol inhibitor PD-135,040 at 1.37 angstrom. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY , 59 pp. 978-981. 10.1107/S0907444903006267.

D

Dashwood, MR; Anand, R; Loesch, A; Filbey, D; Karlsson, M; Souza, DSR; (2003) Improved vein graft patency using a novel n-touch technique is due to preserved nitric oxide synthase. In: Lewis, BS and Halon, DA and Flugelma, MY and Gensini, GF, (eds.) Frontiers in Coronary Artery Disease. (pp. 339-342). Monduzzi Editore: Bologna.

Dashwood, MR; Anand, R; Loesch, A; Souza, DSR; (2003) Vasa vasorum: A system for transporting vasoactive factors in human vein? In: (pp. C57-).

Davies, AK; Woo, P; (2003) Cells cytokines and other mediators. In: Maddison, PJ and Isenberg, DA and Woo, P and Glass, DN, (eds.) Oxford Textbook of Rheumatology. (pp. 399-401). Oxford University Press: Oxford.

Dayal, NA; Isenberg, DA; (2003) Endstage renal failure in primary antiphospholipid syndrome - case report and review of literature. RHEUMATOLOGY , 42 (9) 1128 - 1129. 10.1093/rheumatology/keg302.

Denton, CP; Black, CM; (2003) Pulmonary hypertension in systemic sclerosis. Rheum Dis Clin North Am , 29 (2) 335-vii.

Denton, CP; Black, CM; 351 Study Grp, ; BREATHE-1 Study Grp, ; (2003) Bosentan for scleroderma associated pulmonary arterial hypertension - A subgroup analysis of two placebo controlled trials. In: ARTHRITIS AND RHEUMATISM. (pp. S456 - S456). WILEY-LISS

Denton, CP; Evans, LA; Ong, VH; Shiwen, X; Abraham, DJ; de Crombrugghe, B; Black, CM; (2003) A NOVEL TRANSGENIC MOUSE MODEL FOR SYSTEMIC SCLEROSIS WITH BALANCED UPREGULATION OF TGF beta SIGNALING PATHWAYS. RHEUMATOLOGY , 42 p. 9.

Denton, CP; Zheng, B; Evans, LA; Xu, SW; Ong, VH; Fisher, I; Lazaridis, K; ... de Crombrugghe, B; + view all (2003) Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGF beta) receptor leads to paradoxical activation of TGF beta signaling pathways with fibrosis in transgenic mice. J BIOL CHEM , 278 (27) 25109 - 25119. 10.1074/jbc.M300636200. Gold open access

Dubrey, SW; Burke, MM; Hawkins, PN; Banner, NR; (2003) Cardiac transplantation for amyloid heart disease: The United Kingdom experience. In: (Proceedings) Annual Scientific Conference of the British-Cardiac-Society. (pp. A24-A25). B M J PUBLISHING GROUP

E

Ehrenstein, MR; Evans, JG; Singh, A; Moore, S; Isenberg, DA; Mauri, C; (2003) Expansion of regulatory (CD4+CD25hi) T lymphocytes in the peripheral blood of patients with rheumatoid arthritis who respond to anti-TNF therapy. In: ARTHRITIS AND RHEUMATISM. (pp. S240 - S240). WILEY-LISS

Elkayam, O; Hawkins, PN; Lachmann, H; Caspi, D; (2003) Treatment of renal amyloidosis in rheumatoid arthritis requires further investigation: comment on the case report by Elkayam et al - Reply. ARTHRITIS RHEUM , 48 (11) 3299 - 3300. 10.1002/art.11447.

Erskine, PT; Coates, L; Mall, S; Gill, RS; Wood, SP; Myles, DAA; Cooper, JB; (2003) Atomic resolution analysis of the catalytic site of an aspartic proteinase and an unexpected mode of binding by short peptides. PROTEIN SCIENCE , 12 (8) pp. 1741-1749. 10.1110/ps.0305203.

Esposito, G; Garcia, J; Mangione, P; Giorgetti, S; Corazza, A; Viglino, P; Chiti, F; ... Bellotti, V; + view all (2003) Structural and folding dynamic properties of the T70N variant of human lysozyme*. J BIOL CHEM , 278 (28) 25910 - 25918. 10.1074/jbc.M211000200. Gold open access

F

Fabrizi, L; Taylor, GW; Canas, B; Boobis, AR; Edwards, RJ; (2003) Adduction of the chloroform metabolite phosgene to lysine residues of human histone H2B. CHEMICAL RESEARCH IN TOXICOLOGY , 16 (3) pp. 266-275. 10.1021/tx025565i.

Frohlich, M; Muhlberger, N; Hanke, H; Imhof, A; Doring, A; Pepys, MB; Koenig, W; (2003) Markers of inflammation in women on different hormone replacement therapies. ANN MED , 35 (5) 353 - 361. 10.1080/07853890310007090.

G

Giles, I; (2003) Review of Book: THE ANTIPHOSPHOLIPID SYNDROME. II: AUTOIMMUNE THROMBOSIS. Edited by R. A. Asherson, R. Cervera, J.-C. Piette and Y. Shoenfeld. $149 Elsevier Science, Amsterdam 2002. 480 pages ISBN 0 444 50987 9. UNSPECIFIED

Giles, I; Haley, J; Isenberg, DA; Latchman, DS; Nagl, S; Rahman, A; (2003) Systematic review of sequences of human antiphospholipid and anti-beta 2 glycoprotein I antibodies (aPL). Seminars in Arthritis and Rheumatism , 32 pp. 246-265.

Giles, I; Haq, I; (2003) A career in rheumatology. BMJ (Clinical Research Ed.) , 10 (326) S157-.

Giles, IP; Haley, JD; Nagl, S; Isenberg, DA; Latchman, DS; Rahman, A; (2003) A systematic analysis of sequences of human antiphospholipid and anti-beta(2)-glycoprotein I antibodies: The importance of somatic mutations and certain sequence motifs. SEMIN ARTHRITIS RHEU , 32 (4) 246 - 265. 10.1053/sarh.2003.49994.

Giles, IP; Haley, JD; Nagl, S; Isenberg, DA; Latchman, DS; Rahman, A; (2003) A systematic analysis of sequences of human antiphospholipid and anti-β<inf>2</inf>-glycoprotein I antibodies: The importance of somatic mutations and certain sequence motifs. Seminars in Arthritis and Rheumatism , 32 (4) pp. 246-265. 10.1053/sarh.2003.49994.

Giles, IP; Isenberg, DA; (2003) Autoimmune rheumatic diseases and vasculitis. In: Oxford Textbook of Medicine. (pp. 78-80). Oxford University Press

Giles, IP; Isenberg, DA; Latchman, DS; Rahman, A; (2003) How do antiphospholipid antibodies bind beta(2)-glycoprotein I? ARTHRITIS RHEUM , 48 (8) 2111 - 2121. 10.1002/art.11101.

Giles, IP; Isenberg, DA; Latchman, DS; Rahman, A; (2003) How do antiphospholipid antibodies bind β<inf>2</inf>-glycoprotein I? Arthritis and Rheumatism , 48 (8) pp. 2111-2121. 10.1002/art.11101.

Giles, IP; Lambrianides, N; Latchman, DS; Chen, PP; Chukwuocha, RC; Isenberg, DA; Rahman, A; (2003) The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin. In: (Proceedings) 67th Annual Scientific Meeting of the American-College-of-Rheumatology/38th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S164-S165). WILEY-BLACKWELL

Gill, R; Wood, S; (2003) Structure and phylogeny of insulin. In: Pickup, JC and Williams, G, (eds.) Textbook of diabetes. Wiley-Blackwell

Gillmore, JD; Hutchinson, WL; Mitchell, DA; Herbert, J; Botto, M; Walport, MJ; Pepys, MB; (2003) Studies of serum amyloid P component (SAP) and antinuclear autoimmunity. In: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. (pp. 167A - 168A). LIPPINCOTT WILLIAMS & WILKINS

Gomma, A; Hirschfield, G; Gallimore, J; Lowe, G; Pepys, M; Fox, K; (2003) Systemic markers of inflammation do not predict coronary in-stent restenosis in stable angina patients treated with HMG CoA reductase inhibitors. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. (pp. 34A - 34A). ELSEVIER SCIENCE INC

Gordon, C; Sutcliffe, N; Skan, J; Stoll, T; Isenberg, DA; (2003) Definition and treatment of lupus flares measured by the BILAG index. RHEUMATOLOGY , 42 (11) 1372 - 1379. 10.1093/rheumatology/keg382.

Gorman, C; Leandro, M; Isenberg, DA; (2003) B cell depletion in autoimmune disease. Arthritis Res Ther , 5 S17-S21.

Griffiths, MP; Abraham, DJ; Black, CM; Baker, D; Dziadzio, M; Stratton, RJ; (2003) NICOTINE AND ENDOGENOUS ACETYLCHOLINE ENHANCE THE ANGIOGENIC RESPONSE TO HYPOXIA. RHEUMATOLOGY , 42 pp. 39-40.

H

Hall, C; Woo, P; (2003) Disease of bone and cartilage in children. In: Isenberg, D and Maddison, PJ and Woo, P and Glass, D and Breedveld, FC, (eds.) Oxford Textbook of Rheumatology. (pp. 1164-1173). Oxford University Press: Oxford,UK.

Haq, I; Giles, I; (2003) A career in rheumatology. BMJ , 326 (7397) S157-. 10.1136/bmj.326.7397.S157a.

Hawkins, PN; (2003) Hereditary systemic amyloidosis with renal involvement. JOURNAL OF NEPHROLOGY , 16 (3) 443 - 448.

Hawkins, PN; Lachmann, HJ; McDermott, MF; (2003) Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. NEW ENGL J MED , 348 (25) 2583 - 2584. Green open access
file

Hirschfield, GM; Gallimore, R; Gilbertson, JA; Benson, M; Pepys, MB; (2003) Systemic inflammation and atherogenesis in apoE knockout mice expressing Transgenic human C-reactive protein. In: CIRCULATION. (pp. 41 - 41). LIPPINCOTT WILLIAMS & WILKINS

Hirschfield, GM; Hawkins, PN; (2003) Amyloidosis: new strategies for treatment. INT J BIOCHEM CELL B , 35 (12) 1608 - 1613. 10.1016/S1357-2725(03)00169-9.

Hirschfield, GM; Herbert, J; Kahan, MC; Pepys, MB; (2003) Human C-reactive protein does not protect against acute lipopolysaccharide challenge in mice. J IMMUNOL , 171 (11) 6046 - 6051.

Hirschfield, GM; Pepys, MB; (2003) C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM-INT J MED , 96 (11) 793 - 807. 10.1093/qjmed/hcg134.

Holmes, A; Abraham, DJ; Chen, YJ; Denton, C; Xu, SW; Black, CM; Leask, A; (2003) Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1. J BIOL CHEM , 278 (43) 41728 - 41733. 10.1074/jbc.M305019200. Gold open access

J

Jury, EC; Kabouridis, PS; Abba, A; Mageed, RA; Isenberg, DA; (2003) Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. ARTHRITIS RHEUM , 48 (5) 1343 - 1354. 10.1002/art.10978.

Jury, EC; Kabouridis, PS; Abba, A; Mageed, RA; Isenberg, DA; (2003) Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. Arthritis and Rheumatism , 48 (5) pp. 1343-1354. 10.1002/art.10978.

Jury, EC; Kabouridis, PS; Flores-Borja, F; Mageed, RA; Isenberg, DA; (2003) Abnormal co-localisation of CD45 and lipid rafts is associated with reduced LCK expression in T cells from patients with SLE. In: ARTHRITIS AND RHEUMATISM. (pp. S193 - S193). WILEY-LISS

Jury, EC; Kabouridis, PS; Flores-Borja, F; Mageed, RA; Isenberg, DA; (2003) CD45 IS ABNORMALLY ASSOCIATED WITH LIPID RAFTS IN T LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). RHEUMATOLOGY , 42 5 - 5.

K

Karassa, FB; Magliano, M; Isenberg, DA; (2003) Suicide attempts in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases , 62 (1) pp. 58-60.

Karassa, FB; Magliano, M; Isenberg, DA; (2003) Suicide attempts in patients with systemic lupus erythematosus. ANN RHEUM DIS , 62 (1) 58 - 60.

Khuseyinova, N; Imhof, A; Trischler, G; Rothenbacher, D; Hutchinson, WL; Pepys, MB; Koenig, W; (2003) Determination of C-reactive protein: Comparison of three high-sensitivity immunoassays. CLIN CHEM , 49 (10) 1691 - 1695.

Koenig, W; Sund, M; Frohlich, M; Lowel, H; Hutchinson, WL; Pepys, MB; (2003) Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time. AM J EPIDEMIOL , 158 (4) 357 - 364. 10.1093/aje/kwg135.

Koenig, W; Sund, M; Fröhlich, M; Löwel, H; Hutchinson, WL; Pepys, MB; (2003) Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: The MONICA Augsburg studies, 1984 and 1987. American Journal of Epidemiology , 158 (4) pp. 357-364. 10.1093/aje/kwg135.

Kumar, S; Nagl, S; Kalsi, JK; Ravirajan, CT; Athwal, D; Latchman, DS; Pearl, LH; (2003) Anti-cardiolipin/beta-2 glycoprotein activities co-exist on human anti-DNA antibody light chains. MOL IMMUNOL , 40 (8) 517 - 530. 10.1016/S0161-5890(03)00225-6.

Kumar, S.; Nagl, S.; Kalsi, J.K.; Ravirajan, C.T.; Athwal, D.; Latchman, D.S.; Isenberg, D.A.; (2003) Anti-cardiolipin/β-2 glycoprotein activities co-exist on human anti-DNA antibody light chains. Molecular Immunology , 40 (8) pp. 517-530. 10.1016/S0161-5890(03)00225-6.

L

Lachmann, H.J.; Gallimore, R.; Gillmore, J.D.; Carr-Smith, H.D.; Bradwell, A.R.; Pepys, M.B.; Hawkins, P.N.; (2003) Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. British Journal of Haematology , 122 (1) pp. 78-84. 10.1046/j.1365-2141.2003.04433.x.

Lachmann, HJ; Gallimore, R; Gillmore, JD; Carr-Smith, HD; Bradwell, AR; Pepys, MB; Hawkins, PN; (2003) Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. BRIT J HAEMATOL , 122 (1) 78 - 84.

Lachmann, HJ; Hawkins, PN; (2003) Diagnosis and management of the inherited periodic fever syndromes. CPD Bulletin Immunology and Allergy , 3 (1) pp. 16-19.

Lachmann, HJ; Hawkins, PN; (2003) Novel pharmacological strategies in amyloidosis. NEPHRON CLIN PRACT , 94 (4) C85 - C88. 10.1159/000072490.

Lachmann, HJ; McDermott, MF; Hawkins, PN; (2003) AA amyloidosis complicating the hereditary periodic fever syndromes. In: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. (pp. 115A - 115A). LIPPINCOTT WILLIAMS & WILKINS

Lawman, S; Ehrenstein, MR; (2003) Atorvastatin reduces MHC class II expression and ameliorates autoimmunity in the NZB/NV mouse model of lupus. In: ARTHRITIS AND RHEUMATISM. (pp. S200 - S200). WILEY-LISS

Leandro, MJ; Edwards, JCW; Cambridge, G; Ehrenstein, MR; (2003) B-cell repopulation occurs mainly from naive B cells in patients with rheumatoid arthritis and systemic lupus erythematosus treated with rituximab. In: ARTHRITIS AND RHEUMATISM. (pp. S464 - S464). WILEY-LISS

Leandro, MJ; Ehrenstein, MR; Edwards, JCW; Manson, J; Cambridge, G; Isenberg, DA; (2003) Treatment of refractory lupus nephritis with B lymphocyte depletion. In: ARTHRITIS AND RHEUMATISM. (pp. S378 - S378). WILEY-LISS

Leask, A; Abraham, DJ; (2003) The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. BIOCHEM CELL BIOL , 81 (6) 355 - 363. 10.1139/O03-069.

Leask, A; Holmes, A; Black, CM; Abraham, DJ; (2003) Connective tissue growth factor gene regulation - Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J BIOL CHEM , 278 (15) 13008 - 13015. 10.1074/jbc.M210366200. Gold open access

Leask, A; Holmes, AM; Pontocos, M; Rajkumar, V; Shiwen, X; Stratton, R; Abraham, D; (2003) Mechanism underlying the overexpression of CTGF in scleroderma fibroblasts: Role in elevated expression in scleroderma phenotype. In: (Proceedings) 67th Annual Scientific Meeting of the American-College-of-Rheumatology/38th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S155-S155). WILEY-LISS

M

Manson, JJ; Isenberg, DA; (2003) Antiphospholipid syndrome. INT J BIOCHEM CELL B , 35 (7) 1015 - 1020. 10.1016/S1357-2725(02)00313-8.

Manson, JJ; Isenberg, DA; (2003) The pathogenesis of systemic lupus erythematosus. NETH J MED , 61 (11) 343 - 346.

Mauri, C; Feldmann, M; Williams, RO; (2003) Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response. ARTHRITIS RHEUM , 48 (3) 839 - 845. 10.1002/art.10832.

Mauri, C; Feldmann, M; Williams, RO; (2003) Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response. Arthritis and Rheumatism , 48 pp. 839-845. 10.1084/jem.20021293.

Mauri, C; Gray, D; Mushtaq, N; Londei, M; (2003) Prevention of arthritis by interleukin 10-producing B cells. J EXP MED , 197 (4) 489 - 501. 10.1084/jem.20021293.

Mauri, C.; Gray, D.; Mushtaq, N.; Londei, M.; (2003) Prevention of arthritis by interleukin 10-producing B cells. Journal of Experimental Medicine , 197 (4) pp. 489-501. 10.1084/jem.20021293. Green open access
file

Merlini, G; Bellotti, V; (2003) Molecular mechanisms of amyloidosis. N Engl J Med , 349 (6) pp. 583-596. 10.1056/NEJMra023144.

Miller, FW; Rider, LG; Plotz, PH; Isenberg, DA; Oddis, CV; (2003) Diagnostic criteria for polymyositis and dermatomyositis. LANCET , 362 (9397) 1762 - 1763.

Mpofu, S; Teh, LS; Smith, PJ; Moots, RJ; Hawkins, PN; (2003) Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy. RHEUMATOLOGY , 42 (2) 362 - 366. 10.1093/rheumatology/keg101.

Mukerjee, D; St George, D; Coleiro, B; Knight, C; Denton, CP; Davar, J; Black, CM; (2003) Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. ANNALS OF THE RHEUMATIC DISEASES , 62 (11) pp. 1088-1093. 10.1136/ard.62.11.1088.

Myers, B; Lachmann, H; Russell, NH; (2003) Novel combination chemotherapy for primary (AL) amyloidosis myeloma: clinical, laboratory and serum amyloid-P protein scan improvement. Br J Haematol , 121 (5) pp. 816-817. 10.1046/j.1365-2141.2003.04352.x.

O

Ong, VH; Evans, LA; Shiwen, X; Rajkumar, V; Abraham, DJ; Black, CM; Denton, CP; (2003) EXPRESSION AND FUNCTION OF MONOCYTE CHEMOATTRACTANT PROTEIN-3(MCP-3) IN SCLERODERMA. RHEUMATOLOGY , 42 p. 4.

Ong, VH; Evans, LA; Xu, SW; Fisher, IB; Rajkumar, V; Abraham, DJ; Black, CM; (2003) Monocyte chemoattractant protein 3 as a mediator of fibrosis - Overexpression in systemic sclerosis and the type 1 tight-skin mouse. ARTHRITIS RHEUM , 48 (7) 1979 - 1991. 10.1002/art.11164.

P

Pepys, M; (2003) Dame Sheila Patricia Violet Sherlock. Biogr Mem Fellows R Soc , 49 pp. 475-493.

Pepys, M; (2003) Dame Sheila Patricia Violet Sherlock. 31 March 1918 – 30 December 2001 Elected FRS 2001. Biographical Memoirs of Fellows of the Royal Society , 49 pp. 475-493. 10.1098/rsbm.2003.0028.

Pepys, M.B.; Bybee, A.; Booth, D.R.; Bishop, M.T.; Will, R.G.; Little, A.-M; Prokupek, B.; (2003) MHC typing in variant Creutzfeldt-Jakob disease. The Lancet , 361 (9356) pp. 487-489. 10.1016/S0140-6736(03)12455-5.

Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; (2003) MHC typing in variant Creutzfeldt-Jakob disease. LANCET , 361 (9356) 487 - 489.

Pepys, MB; Hirschfield, GM; (2003) C-reactive protein: a critical update. J CLIN INVEST , 111 (12) 1805 - 1812. 10.1172/JCI200318921.

Pepys, MB; Hirschfield, GM; (2003) C-reactive protein: a critical update. The Journal of clinical investigation , 112 (2) p. 299. 10.1172/JCI200318921C.

Ponticos, M; Holmes, AM; Rajkumar, V; Wen, XS; Leask, A; Abraham, DJ; Black, CM; (2003) Connective tissue growth factor (CTGF) mediates extracellular matrix deposition in bleomycin-induced lung fibrosis via the MEK/ERK signaling pathways. In: ARTHRITIS AND RHEUMATISM. (pp. S156 - S156). WILEY-LISS

R

Rahman, A; (2003) Cytokines in systemic lupus erythematosus, London, UK. ARTHRITIS RESEARCH & THERAPY , 5 (4) pp. 160-164. 10.1186/ar767.

Rahman, A; Isenberg, DA; (2003) Systemic lupus erythematosus and related disorders. In: Oxford Textbook of Medicine. (pp. 80-90). Oxford University Press

Rajkumar, V; Black, C; Abraham, D; (2003) PHENOTYPIC CHANGES IN MICROVASCULAR PERICYTES DURING EXCISIONAL WOUND HEALING IN TRANSGENIC MICE. RHEUMATOLOGY , 42 p. 139.

Ramsey-Goldman, R; Isenberg, DA; (2003) Systemic lupus erythematosus measures. Arthritis Care and Research , 49 S225-S233.

Rider, LG; Giannini, EH; Harris-Love, M; Joe, G; Isenberg, D; Pilkington, C; Lachenbruch, PA; (2003) Defining Clinical Improvement in Adult and Juvenile Myositis. Journal of Rheumatology , 30 (3) pp. 603-617.

Roberts, MM; Coker, AR; Fossati, G; Mascagni, P; Coates, ARM; Wood, SP; (2003) Mycobacterium tuberculosis chaperonin 10 heptamers self-associate through their biologically active loops. JOURNAL OF BACTERIOLOGY , 185 (14) pp. 4172-4185. 10.1128/JB.185.14.4172-4185.2003.

S

Sen, D; Isenberg, DA; (2003) Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. LUPUS , 12 (9) 651 - 658. 10.1191/0961203303lu456rr.

Shiwen, X; Dashwood, MR; Denton, CP; Renzoni, EA; Bou-Gharios, G; du Bois, R; Leask, A; ... Black, CM; + view all (2003) Response of human lung fibroblast cells to stimulation by endothelin-1: Involvement of ras/MEK/ERK and PI3 kinase. In: (Proceedings) 67th Annual Scientific Meeting of the American-College-of-Rheumatology/38th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S39-S39). WILEY-LISS

Shiwen, X; Dashwood, MR; Denton, CP; Renzoni, EA; Holmes, AM; Bou-Gharious, G; Stratton, RJ; ... Black, CM; + view all (2003) IDENTIFICATION OF THE SIGNALLING PATHWAY GENES IN PULMONARY FIBROBLASTS STIMULATED BY ENDOTHELIN-1. RHEUMATOLOGY , 42 p. 140.

Shiwen, X; Scarraf, C; Harris, A; Bou-Gharios, G; Eastwood, M; Abraham, D; Black, C; (2003) GENE EXPRESSION PROFILING OF CONNECTIVE TISSUE FIBROBLASTS IN RESPONSE TO APPLIED BIO-MECHANICAL FORCE. RHEUMATOLOGY , 42 p. 139.

Silva, CA; Sultan, SM; Isenberg, DA; (2003) Pregnancy outcome in adult-onset idiopathic inflammatory myopathy. RHEUMATOLOGY , 42 (10) 1168 - 1172. 10.1093/rheumatology/keg318.

Smyth, AE; MacGregor, AJ; Mukerjee, D; Brough, GM; Black, CM; Denton, CP; (2003) A cross-sectional comparison of three self-reported functional indices in scleroderma. Rheumatology (Oxford) , 42 (6) pp. 732-738. 10.1093/rheumatology/keg145.

Sultan, SM; Begum, S; Isenberg, DA; (2003) Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. RHEUMATOLOGY , 42 (2) 230 - 234. 10.1093/rheumatology/keg069.

Swale, VJ; Perrett, CM; Denton, CP; Black, CM; Rustin, MHA; (2003) Etanercept-induced systemic lupus erythematosus. Clin Exp Dermatol , 28 (6) pp. 604-607.

T

Terwilliger, TC; Park, MS; Waldo, GS; Berendzen, J; Hung, LW; Kim, CY; Smith, CV; ... Rupp, B; + view all (2003) The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology. TUBERCULOSIS , 83 (4) pp. 223-249. 10.1016/S1472-9792(03)00051-9.

V

Visai, L; De Rossi, E; Valtulina, V; Casolini, F; Rindi, S; Guglierame, P; Pietrocola, G; ... Speziale, P; + view all (2003) Identification and characterization of a new ligand-binding site in FnbB, a fibronectin-binding adhesion from Streptococcus dysgalactiae. Biochimica et Biophysica Acta: proteins and proteomics , 1646 pp. 173-183.

Vogan, CL; Maskrey, BH; Taylor, GW; Henry, S; Pace-Asciak, CR; Clare, AS; Rowley, AF; (2003) Hepoxilins and trioxilins in barnacles: an analysis of their potential roles in egg hatching and larval settlement. J Exp Biol , 206 (Pt 18) pp. 3219-3226. 10.1242/jeb.00542.

van der Slot, AJ; Zuurmond, AM; Bardoel, AFJ; Wijmenga, C; Pruijs, HEH; Sillence, DO; Brinckmann, J; ... Bank, RA; + view all (2003) Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J BIOL CHEM , 278 (42) 40967 - 40972. 10.1074/jbc.M307380200. Gold open access

W

Wechalekar, AD; Chen, CI; Sutton, D; Reece, D; Voralia, M; Stewart, AK; (2003) Intermediate dose thalidomide (200 mg daily) has comparable efficacy and less toxicity than higher doses in relapsed multiple myeloma. LEUKEMIA LYMPHOMA , 44 (7) 1147 - 1149. 10.1080/1042819031000067918.

Wijeyekoon, JB; Isenberg, DA; (2003) Treatment focus: systemic lupus erythematosus. Hospital Pharmacy Europe (April/Ma) pp. 31-34.

X

Xu, SW; Dashwood, MR; Denton, CP; Renzoni, EA; Bou-Gharis, G; du Bois, R; Leask, A; ... Black, CM; + view all (2003) Response of human lung fibroblast cells to stimulation by endothelin-1: Involvement of ras/MEK/ERK and p13 kinase. In: (Proceedings) 67th Annual Scientific Meeting of the American-College-of-Rheumatology/38th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S156-S156). WILEY-LISS

Z

Zuccotti, S; Rosano, C; Mangione, P; Bellotti, V; Bolognesi, M; (2003) Preliminary crystallographic characterization of the human beta2 microglobulin His31Tyr mutant in a tetrameric assembly. Acta Crystallogr D Biol Crystallogr , 59 (Pt 7) pp. 1270-1272. 10.1107/s0907444903009193.

This list was generated on Sun Aug 18 06:50:00 2019 BST.